PBRM1 presents a potential prognostic marker and therapeutic target in duodenal papillary carcinoma

BACKGROUND: Due to its rarity, duodenal papillary carcinoma (DPC) is seldom studied as a unique disease and no specific molecular features or treatment guidelines are provided. METHODS: Whole‐exome sequencing was performed to gain new insights into the DPC mutation landscape and to identify potentia...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Xujun, Xu, Ji, Niu, Nan, Xu, Guoxi, Zhu, Honglin, Liu, Zhengchuang, Mou, Yiping, Qian, Zhengyuan, Wang, Huiju, Hu, Junfeng, Ma, Tonghui, Ma, Jie, Tao, Houquan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523678/
https://www.ncbi.nlm.nih.gov/pubmed/36178086
http://dx.doi.org/10.1002/ctm2.1062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9523678/
https://www.ncbi.nlm.nih.gov/pubmed/36178086
http://dx.doi.org/10.1002/ctm2.1062

Ejemplares similares